Companies like Philips Healthcare (Netherland), Honeywell (US) and PointClickCare (Canada) are increasing their initiatives to develop smart hardware and software solutions for personalized care. For instance, in January 2025, iWOW (Singapore), introduced two groundbreaking age-tech products, namely the BOP Monitor and BOP Presence at CES 2025. These products are a part of a comprehensive suite of IoT solutions aims to detect accidental fall and monitor the moment of senior at home to keep them...

The RNA sequencing service market, valued at USD 3.3 billion in 2025, is projected to reach USD 3.6 billion in 2026 and USD 7.5 billion by 2035, with a 8.5% CAGR during the forecast period 2026 to 2035. RNA sequencing was first introduced by Fredrick Sanger in 1977, who used chain termination method, also known sanger sequencing method / first generation sequencing method. Over time, RNA sequencing service market has witnessed several technological advancements, and different methods of RNA seq...

These 3D cell culture models and organoids are used for studying drug safety and efficacy. In addition to clinical studies, the growing focus on stem cell therapy and regenerative medicine has further bolstered the demand for advanced 3D cell cultures and organoids.Considering the significances of advanced technology-based models, several industrial players are aiming to develop advanced organoid technologies and platforms for drug discovery and clinical studies. For instance, in July 2025, MD A...

Several research programs are underway to develop advanced epigenetic therapies for targeting cancer or solid tumors. For instance, in January 2025, a study published in John Hopkins Medicine highlighted that a team of researchers at Johns Hopkins Kimmel Cancer Center and Chinese Academy of Sciences identify new epigenetic approach to target colorectal cancer. During this study, researchers found a mouse protein that disrupts cancer-causing chemicals within genes associated with colorectal cance...

Several industrial players are focusing on the expansion of their products and services. In May 2025, Elis Bio (spun-out of the University of Chiacago) announced the launch of SuperMethyl™, a fast bisulfite conversion kit which provides 99.5% methyl conversion within ten minutes, in 2024 Chicago BioCapital Summit. Earlier, in August 2024, Genentech signed a licensing agreement worth up to USD 2 billion with Sangamo Therapeutics to develop genomic medicines for treating neurodegenerative diseas...

The global genotoxicity testing market, valued at USD 1.4 billion in 2025, is projected to reach USD 1.5 billion in 2026 and USD 2.7 billion by 2035, with a 6.8% CAGR during the forecast period 2026 to 2035. Genotoxicity refers to the property of hazardous (physical, chemical and biological) agents to cause damage to genetic information present within a cell. At present, more than 80 industry and non-industry players offer a variety of assays, such as Ames assay, micronucleus assay, chromosomal...

The global healthcare technology management market, valued at USD 30.09 billion in 2024, is projected to reach USD 34.18 billion in 2025 and USD 98.48 billion by 2035, representing a CAGR of 11.2% during the forecast period. As per the report of HIPAA journal, in 2024, there are over 14 data breaches cases that compromised over 1 million healthcare records, affecting around 1,90,000,000 million individuals. Healthcare technology management refers to the multidisciplinary approach that encompasse...

the market for veterinary digital pathology is also driven by the rising adoption of companion animals, and willing of pet owners to spend on their companion animals health. Considering the rising opportunities, several market players have shown active interest in the field for digital pathology innovations. For instance, in June 2025, MUSE Microscopy (US) launched MUSE veterinary digital pathology, the first-of-its-kind tissue-to-direct digital imaging to provide same-day result for tissue biop...

With increasing demand across healthcare and pharmaceutical industries, several market players are actively exploring new possibilities for innovations in this field. Market players, such as MGI Tech (China), Illumina (US), and NVIDIA (US) are leveraging partnerships for developing AI based digital genome technologies. For instance, in June 2025, MGI Tech (China) signed a strategic collaboration with GenePowerRx (India) to revolutionize the predictive healthcare and precision medicine landscape...

The global genome editing market, valued at $4.25 billion in 2025, is projected to reach $5.29 billion in 2026 and $13.36 billion by 2035, representing a CAGR of 10.8% during the forecast period 2026 to 2035. more than 1,100 active clinical trials are evaluating gene therapies across various phases of clinical studies. According to the World Health Organization (WHO), 10 out of every 1,000 individuals are affected by genetic disorders, with over 70 million people worldwide living with such condi...

The AI-driven personalized nutrition has been further bolstered by the rising adoption of medical wearable devices, and smartphones that help to collect vital information for disease monitoring and management. Moreover, AI integration with nutrigenomics can help in determining vast amount of data generated through genomics, and metabolomics. Notably, this field is at the forefront of innovation, catering the attention of industrial players.For instance, in February 2025, Fay (US), a digital nutr...

The global non-viral drug delivery systems market, valued at USD 8.6 billion in 2025, is projected to reach USD 11.3 billion in 2026 and USD 20.4 billion by 2035, with a 6.8% CAGR during the forecast period 2026 to 2035. In September 2024, NanoSyrinx raised USD 13 million in a seed funding round, in order to advance its intracellular nanosyringe technology that is aimed to target biologics to the sites that are difficult to target within the cell. The market report presents an in-depth analysis...

Several market players are leveraging partnerships and collaborations to develop cost-effective and cutting-edge solutions for microbiome diagnostics. For instance, in February 2025, Leucine Ruch Bio (India) announced a strategic partnership with Precision Diagnosticos (Brazil) to expand BugSpeaks (Leucine Rich Bio’s flagship microbiome testing technology) to Brazilian market. Besides technology expansion, the industrial players also focus on initiating education programs to raise awareness ab...

The global medical device CRO market, valued at USD 20.4 billion in 2025, is projected to grow to USD 22.0 billion in 2026 and USD 43.6 billion by 2035, representing a CAGR of 7.9% during the forecast period 2026 to 2035. The demand for advanced medical devices has intensified the pressure on medical device companies to not only meet rigorous regulatory standards but also expand their product offerings.

The global KRAS market size, valued at USD 476 million in 2024, is projected to reach USD 557 million in 2025 and USD 3,894 million by 2035, representing a CAGR of 21% during the forecast period. One of these oncogenic mutations is KRAS, which was identified to be associated with nearly 30% of cancer in humans. One of the key objectives of KRAS market report was to estimate the current market size, opportunity and the market growth potential, over the forecast period, till 2035. We have provided...

The global antiviral drugs market size is estimated to grow from USD 69 billion in 2025 to reach USD 74 billion in 2026 and USD 127 billion by 2035, representing a higher CAGR of 6.1% during the forecast period 2026 to 2035. According to the National Institute for Health’s reports, around 52 million (33%) deaths are caused by infectious diseases annually. COVID-19 is one of the latest examples of an infectious disease that caused 3 million deaths worldwide. Before COVID-19, Human Immunodeficie...

The spatial genomics and transcriptomics market, valued at USD 6.5 billion in 2025, is projected to reach USD 7.3 billion in 2026 and USD 20.1 billion by 2035, with a 11.9% CAGR during the forecast period 2026 to 2035. Researchers have focused their efforts from decoding the primary sequence of genes to analyzing the location and interaction of cell types, and biomarkers (primarily, DNA, RNA and proteins), through a process known as spatial phenotyping. These spatial phenotyping platforms can be...

The global 3D cell culture market, valued at USD 2.16 billion in 2025, is projected to reach USD 2.61 billion in 2026 and USD 8.90 billion by 2035, with a 14.6% CAGR during the forecast period 2026 to 2035. Driven by the increasing requirement of animal model alternatives, the 3D cell culture market is anticipated to grow at a higher rate during the forecast period. According to our projection, use of 3d cell culture systems for cancer research is dominating the market and is likely to hold 41%...

The DNA data storage market size is estimated to be worth USD 34.8 million in 2024 and is expected to reach USD 532 million by 2035 growing at a CAGR of 28% during the forecast period, till 2035. The ongoing technological advancements, rising popularity of social media, use of virtual platforms during the COVID-19 pandemic and digitalization of the various aspects in the modern world have led to the generation of colossal amount of digital data. The reliable and secure storage and accessibility...

The global clinical trial patient recruitment services market, valued at USD 11.8 billion in 2025, is projected to reach USD 12.8 billion in 2026 and USD 26.2 billion by 2035, with a 8.3% CAGR during the forecast period 2026 to 2035. Studies suggest that around 40% of the total investment made for the development of a drug candidate is dedicated to clinical trials. However, around 80% of the clinical trials are delayed due to insufficient patient recruitment. Further, retaining patients is also...